Skip to content
This event took place on 24th September 2020, so you won't be able to enquire. They may run the event again in the future. Contact the member by visiting their profile using the 'Member Profile' link above.

This Webinar aims to explore the latest developments in treating high risk AML patients with intensive chemotherapy: 1. To review the current treatment landscape in high risk AML and support the understanding of the prognosis for those patients diagnosed; 2. To educate the audience around the latest data for Vyxeos Liposomal in this patient population and best practice examples of how to manage patients from diagnosis through to treatment with therapies like Vyxeos Liposomal; 3. Panel discussion to answer audience questions and explore learnings; challenges and best practice during and outside of a pandemic; such as COVID-19.


Become a CPD Provider
Want to see your company here?Become a CPD Provider